Costs of Next-Generation Sequencing Assays in Non-Small Cell Lung Cancer: A Micro-Costing Study

Background: Next-generation sequencing (NGS) of tumor genomes has changed and improved cancer treatment over the past few decades. It can inform clinicians on the optimal therapeutic approach in many of the solid and hematologic cancers, including non-small lung cancer (NSCLC). Our study aimed to de...

Descripción completa

Detalles Bibliográficos
Autores principales: Kumar, Srishti, Bennett, Alexandria, Campbell, Pearl A., Palidwor, Gareth, Lo, Bryan, Perkins, Theodore J., Nochaiwong, Surapon, Sekhon, Harmanjatinder S., Stewart, David J., Thavorn, Kednapa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9330154/
https://www.ncbi.nlm.nih.gov/pubmed/35892985
http://dx.doi.org/10.3390/curroncol29080416

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9330154/
https://www.ncbi.nlm.nih.gov/pubmed/35892985
http://dx.doi.org/10.3390/curroncol29080416

Ejemplares similares